102 Conversely, various groups are advocating for your incorporation of novel markers, like a elaborate karyotype55 or epigenetic subsets, 27,28 into clinical follow. These novel prognostic and/or predictive designs will have to be validated in cohorts of clients dealt with with focused agents.Well That is embarassing! Our web page encountered an u